Source: Zacks

Surmodics: SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System

Surmodics launches the Pounce XL Thrombectomy System, aiming to enhance clot removal efficiency, improve patient outcomes, and expand its portfolio of vascular interventions.

Read full article »
Annual Revenue
$100-500M
Employees
250-500
Gary R. Maharaj's photo - President & CEO of Surmodics

President & CEO

Gary R. Maharaj

CEO Approval Rating

90/100

Read more